Portrait of Kanav Jain

Product leader · hands-on builder · Chicago · US and Australian citizen, open to relocation

I turn new AI capabilities into products that hospitals and other cautious institutions will deploy

calls on an average workday
300,000+
health systems using it
250+
since I left, still running
9 years

Doximity Dialer, which I originated as founding product lead. Doximity’s own figures, February 2026.

14 years as a product leader and hands-on builder, making products in clinical care, oncology and AI, after training in biomedical engineering and molecular-biology research. See where I’d fit →

DoximityEpicTranscarentCancerCompass / CTCA MarketplaceAndwiseMemorial Sloan Kettering Cancer CenterTechstars

The two products deal with one problem: records that go out of date while people still rely on them, like a guideline that no longer matches the evidence.

  • Refract Change tracking: records every edit to a source, such as a Wikipedia article, and what each edit changed. A published test set of 16,146 recorded edits, reproducible from the same source.
  • Fast Harm, Slow Repair Agent error evaluation: a draft benchmark protocol for measuring how far AI mistakes propagate through tools and what remains wrong after correction. No results yet.

I come in before there’s a roadmap, build an unproven idea far enough to see whether it holds, and then decide what to scale, what to cut, and who should own it.

I originated Doximity Dialer, led R&D at CancerCompass, and co-founded Andwise. Andwise showed in year one that physicians wanted it; I did not work out who would pay until year two, and by then every path that could fund the company made someone other than the physician the paying customer. In 2024, with funding and engagement short, I shut it down rather than rebuild it around the physician’s employer or financial advisor as the customer. Since then I have built systems myself: NextConsensus, Ambit and the tools under them.

Revised